US2010009425A1PendingUtilityA1
Glycoprotein synthesis
Est. expiryOct 16, 2022(expired)· nominal 20-yr term from priority
C12P 21/005C07K 1/00C12N 15/09
70
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Methods for making glycoproteins, both in vitro and in vivo, are provided. One method involves incorporating an unnatural amino acid into a protein and attaching one or more saccharide moieties to the unnatural amino acid. Another method involves incorporating an unnatural amino acid that includes a saccharide moiety into a protein. Proteins made by both methods can be further modified with additional sugars.
Claims
exact text as granted — not AI-modified1 - 57 . (canceled)
58 . A composition comprising an antibody that comprises an unnatural amino acid, wherein the composition additionally comprises a recombinant glycosylase that glycosylates the unnatural amino acid.
59 . The composition of claim 58 , wherein the antibody is a polyclonal, monoclonal, chimeric, or single chain antibody.
60 . The composition of claim 58 , wherein the antibody is a fragment of a full-length immunoglobulin.
61 . The composition of claim 58 , wherein the composition comprises a translation system, cell or cell lysate that comprises the antibody and the recombinant glycosylase.
62 . The composition of claim 61 , wherein the translation system, cell, or cell lysate comprises a recombinant nucleic acid that comprises a selector codon and that encodes at least one polypeptide chain of the antibody, an orthogonal tRNA (OtRNA) that recognizes the selector codon, and an orthogonal aminoacyl tRNA synthetase (ORS) that aminoacylates the OtRNA with the unnatural amino acid, wherein the translation system, cell or cell lysate incorporates the unnatural amino acid into the antibody in response to the selector codon.Join the waitlist — get patent alerts
Track US2010009425A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.